复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688505 复旦张江

已收盘 10-31 15:00:01

{"stockData":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":8.7,"timestamp":1730358001000,"preClose":8.68,"halted":0,"volume":4973809,"delay":0,"floatShares":711000000,"shares":1036999999,"eps":0.1015,"marketStatus":"已收盘","marketStatusCode":5,"change":0.02,"latestTime":"10-31 15:00:01","open":8.7,"high":8.83,"low":8.61,"amount":43426700,"amplitude":0.0253,"askPrice":8.7,"askSize":78,"bidPrice":8.69,"bidSize":84,"shortable":0,"etf":0,"ttmEps":0.1015,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730424600000},"adr":0,"adjPreClose":8.68,"symbolType":"stock_kcb","openAndCloseTimeList":[[1730338200000,1730345400000],[1730350800000,1730358000000]],"highLimit":9.55,"lowLimit":7.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1036572100,"pbRate":3.83,"roa":"--","roe":"3.66%","epsLYR":0.11,"committee":-0.277494,"marketValue":9018000000,"floatMarketCap":6182000000,"peRate":85.714288,"changeRate":0.0023,"turnoverRate":0.007,"status":0,"afterMarket":{"amount":4350,"volume":500,"close":8.7,"buyVolume":0,"sellVolume":300,"time":1730360039464,"indexStatus":"已收盘 10-31 15:30:00","preClose":8.68}},"requestUrl":"/m/hq/s/688505/wiki","defaultTab":"wiki","newsList":[{"id":"2479708288","title":"【港股通】复旦张江(01349)奥贝胆酸片上市申请获得药监局受理 拟用于原发性胆汁性胆管炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2479708288","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479708288?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:20","pubTimestamp":1730366412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 复旦张江(01349)公布，公司的附属公司泰州复旦张江药业有限公司(“泰州复旦张江”)收到国家药品监督管理局核准签发的《受理通知书》，奥贝胆酸片(规格：5mg、10mg)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请获得受理。据悉，该药物属于法尼酯X受体(Farnesoid Xreceptor，“FXR”)激动剂。FXR是一种在肝脏和肠道中高水平表达的核受体，在胆酸代谢调节中起关键性作用。该药物是化学药品3类仿制药，其首个目标适应症为原发性胆汁性胆管炎。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200915/NzY4ZGM4YzYyNTA1ODM4NTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NzY4ZGM4YzYyNTA1ODM4NTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0239","YANG","HSCEI","HSTECH","01349","688505"],"gpt_icon":0},{"id":"2479771323","title":"复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2479771323","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479771323?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:55","pubTimestamp":1730364948,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江 发布公告，该公司的附属公司泰州复旦张江药业有限公司收到国家药品监督管理局核准签发的《受理通知书》，奥贝胆酸片(该药物)用于治疗原发性胆汁性胆管炎的药物上市申请获得受理。该药物是化学药品 3 类仿制药，其首个目标适应症为原发性胆汁性胆管炎。集团对于原研药物的专利限制进行了突破，并在中国大陆获得了相应的专利授权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","01349","BK0239","BK1191"],"gpt_icon":0},{"id":"2479710397","title":"复旦张江(01349.HK)奥贝胆酸片治疗胆管炎获受理药物上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2479710397","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479710397?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:53","pubTimestamp":1730364780,"startTime":"0","endTime":"0","summary":"复旦张江(01349.HK) 公布，附属泰州复旦张江收到国家药监局核准签发的《受理通知书》，奥贝胆酸片用于治疗原发性胆汁性胆管炎的药物上市申请获得受理。该药物属于法尼酯X受体激动剂(FXR)。FXR是一种在肝脏和肠道中高水平表达的核受体，在胆酸代谢调节中起关键性作用。该药物是化学药品3类仿制药，其首个目标适应症为原发性胆汁性胆管炎。 (ha/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20181120173426512_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20181120173426512_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1393029/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01349","BK0239","688505"],"gpt_icon":0},{"id":"2479977627","title":"复旦张江(688505.SH)：奥贝胆酸片药品上市申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2479977627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479977627?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:40","pubTimestamp":1730364049,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(688505.SH)发布公告，公司全资子公司泰州复旦张江药业有限公司于近日收到国家药品监督管理局下发的关于奥贝胆酸片(规格：5mg、10mg)用于治疗原发性胆汁性胆管炎(PBC)的境内生产药品注册上市许可申请的《受理通知书》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1191","688505","01349"],"gpt_icon":0},{"id":"2479972089","title":"复旦张江10月31日遭主力抛售514万元 环比增加252.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479972089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479972089?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:18","pubTimestamp":1730359097,"startTime":"0","endTime":"0","summary":"10月31日, 复旦张江股价涨0.23%，报收8.70元，成交金额4342万元，换手率0.70%，振幅2.53%，量比0.79。复旦张江今日主力资金净流出514万元，连续5日净流出，上一交易日主力净流出146万元，今日环比增加252.05%。|10月31日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N强达电路|29.90%|#|风光股份|5.81%|#|立航科技|5.50%|#|赢时胜|4.60%|#|三超新材|4.31%|#|任子行|4.23%|#|星华新材|4.09%|#|王子新材|3.89%|#|中公教育|3.73%|#|大众交通|3.51%|复旦张江所在的化学制药行业，今日主力净流出2.48亿元，行业排名15/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031153457a2000ad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031153457a2000ad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2479623423","title":"复旦张江10月29日主力资金流出1150万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479623423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479623423?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:19","pubTimestamp":1730186363,"startTime":"0","endTime":"0","summary":"10月29日, 复旦张江股价跌4.00%，报收8.65元，成交金额6597万元，换手率1.06%，振幅4.66%，量比1.19。复旦张江今日主力资金净流出1150万元，连续3日净流出，上一交易日主力净流出951万元，今日环比增加20.93%。该股近5个交易日下跌2.81%，主力资金累计净流出3044万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出9508万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154159ab7df730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154159ab7df730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2479448907","title":"复旦张江(01349)下跌5.02%，报2.84元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479448907","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479448907?lang=zh_cn&edition=full","pubTime":"2024-10-29 13:07","pubTimestamp":1730178453,"startTime":"0","endTime":"0","summary":"10月29日，复旦张江(01349)盘中下跌5.02%，截至13:07，报2.84元/股，成交2932.74万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售，致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工，且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势，已成功在香港主板上市，股票代码1349。截至2024年三季报，复旦张江营业总收入5.49亿元、净利润8646.86万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/29130744650500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","01349","BK1191","688505"],"gpt_icon":0},{"id":"2478114429","title":"南向资金10月25日净买入复旦张江11.60万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2478114429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478114429?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:30","pubTimestamp":1730079013,"startTime":"0","endTime":"0","summary":"10月25日, 南向资金增持复旦张江11.60万股，连续3日增持。截止当日收盘，港股通共持有复旦张江11106.71万股，占流通股34.06%。复旦张江近5个交易日上涨13.53%，港股通累计增持522.80万股；近20个交易日上涨60.64%，港股通累计增持337.00万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028093132ab799116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028093132ab799116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK1191","01349"],"gpt_icon":0},{"id":"2478112119","title":"金十数据整理：每日港股市场要闻速递（10月28日 周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2478112119","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478112119?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:12","pubTimestamp":1730077936,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1240","BK1542","IE00BGHQF631.EUR","601633","HSTECH","LU0731783048.USD","LU1997245177.USD","688505","BK0010","LU0648001328.SGD","01349","LU1794554557.SGD","LU0742537680.HKD","BK0012","03333","BLK","BK1128","IE00B42XCP33.USD","BK0188","BK1565","LU1481011671.HKD","LU2328871848.SGD","IE00BVYPNW00.USD","LU1074936037.SGD","GWLLY","IE00B3PB1722.GBP","00136","BK4534","IE0034224299.USD","02333","06666","LU1670627923.USD","HSCEI","LU0130102774.USD","00390","LU1997245094.SGD","BK4567","601390","YANG","BK0264","82333","IE00B3QW5Z07.USD","BK1590","00708","07226","BK0277","BK1539","LU1201861249.SGD","LU2264538146.SGD"],"gpt_icon":0},{"id":"2478931731","title":"复旦张江(688505.SH)发布前三季度业绩 净利润8646.86万元 同比下降3.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478931731","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478931731?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:38","pubTimestamp":1729867104,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(688505.SH)披露2024年第三季度报告，该公司前三季度实现营业收入5.49亿元，同比下降22.47%。归属于上市公司股东的净利润8646.86万元，同比下降3.81%。归属于上市公司股东的扣除非经常性损益的净利润5450.05万元，同比下降23.76%。基本每股收益为0.08元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","01349"],"gpt_icon":0},{"id":"2478604533","title":"《业绩》复旦张江(01349.HK)首三季纯利8,646.86万人民币 按年跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478604533","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478604533?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:58","pubTimestamp":1729850280,"startTime":"0","endTime":"0","summary":"复旦张江(01349.HK) 公布截至今年9月底止首三季业绩，营业收入录5.49亿元人民币(下同)，按年跌22.47%。纯利8,646.86万元，按年跌3.81%；每股盈利0.08元。(gc/u)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/12中期业绩普通股息：人民币 0.02 (相当于港元 0.0217)2024/04/29第一季业绩无派息2024/03/28末期业绩普通股息：人民币 0.07 (相当于港元 0.0757)2023/10/30第三季业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205163855946_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205163855946_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1391269/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01349","688505","BK0239"],"gpt_icon":0},{"id":"2478796609","title":"复旦张江：前三季度净利润约8647万元 同比减少3.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478796609","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478796609?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:54","pubTimestamp":1729850086,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","BK1191","688505","01349"],"gpt_icon":0},{"id":"2478060951","title":"复旦张江(01349)发布前三季度业绩，净利润8646.86万元 同比减少3.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478060951","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478060951?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:48","pubTimestamp":1729849708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江 发布截至2024年9月30日止9个月业绩，该集团取得营业收入人民币5.49亿元，同比减少22.47%;归属于上市公司股东的净利润8646.86万元，同比减少3.81%;基本每股收益0.08元。因此，集团绝大部分在研项目支出均于产生时确认为费用。报告期内，公司积极推动研发项目进展，其中抗Trop2抗体偶联 SN38项目已进入III期临床，其他多个项目亦推进顺利。本期临床、研究用材料及委外研发费用均上升明显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","01349"],"gpt_icon":0},{"id":"2477517726","title":"复旦张江(01349)上涨5.14%，报3.07元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477517726","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477517726?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:01","pubTimestamp":1729735280,"startTime":"0","endTime":"0","summary":"10月24日，复旦张江(01349)盘中上涨5.14%，截至10:01，报3.07元/股，成交730.32万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售，致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工，且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势，已成功在香港主板上市，股票代码1349。截至2024年中报，复旦张江营业总收入4.08亿元、净利润7047.31万元。10月25日，复旦张江将披露2024财年三季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/24100144374696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","01349","688505","BK1191"],"gpt_icon":0},{"id":"2477807965","title":"复旦张江(01349)股价显著上升11.278%，现价港币$2.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2477807965","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477807965?lang=zh_cn&edition=full","pubTime":"2024-10-21 11:35","pubTimestamp":1729481700,"startTime":"0","endTime":"0","summary":"[上升股]复旦张江(01349) 股价在上午11:35比前收市价显著上升11.278%，现股价为港币$2.96。至目前为止，今日最高价为$2.96，而最低价为$2.66。总成交量为751.8万股，总成交金额为港币$2.092千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410211091/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0239","01349","BK1191","688505"],"gpt_icon":0},{"id":"2477213025","title":"复旦张江(01349)上涨5.64%，报2.81元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477213025","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477213025?lang=zh_cn&edition=full","pubTime":"2024-10-21 09:44","pubTimestamp":1729475057,"startTime":"0","endTime":"0","summary":"10月21日，复旦张江(01349)盘中上涨5.64%，截至09:44，报2.81元/股，成交389.17万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售，致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工，且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势，已成功在香港主板上市，股票代码1349。截至2024年中报，复旦张江营业总收入4.08亿元、净利润7047.31万元。10月25日，复旦张江将披露2024财年三季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/21094444224098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688505","BK1191","01349"],"gpt_icon":0},{"id":"2476195510","title":"复旦张江10月17日遭主力抛售926万元 环比增加11475.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476195510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476195510?lang=zh_cn&edition=full","pubTime":"2024-10-17 15:18","pubTimestamp":1729149525,"startTime":"0","endTime":"0","summary":"10月17日, 复旦张江股价跌1.83%，报收8.05元，成交金额3984万元，换手率0.68%，振幅3.78%，量比0.65。复旦张江今日主力资金净流出926万元，连续3日净流出，上一交易日主力净流出8万元，今日环比增加11475.00%。该股近5个交易日下跌9.04%，主力资金累计净流出2380万元；近20日主力资金累计净流出6441万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410171534319f49bae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410171534319f49bae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2475512471","title":"复旦张江(01349)下跌5.26%，报2.52元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475512471","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475512471?lang=zh_cn&edition=full","pubTime":"2024-10-15 14:58","pubTimestamp":1728975481,"startTime":"0","endTime":"0","summary":"10月15日，复旦张江(01349)盘中下跌5.26%，截至14:58，报2.52元/股，成交1606.86万元。上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售，致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工，且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势，已成功在香港主板上市，股票代码1349。截至2024年中报，复旦张江营业总收入4.08亿元、净利润7047.31万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/15145844006394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK0239","01349","688505"],"gpt_icon":0},{"id":"2474594320","title":"复旦张江10月11日主力资金流出1185万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2474594320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474594320?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:18","pubTimestamp":1728631118,"startTime":"0","endTime":"0","summary":"10月11日, 复旦张江股价跌6.33%，报收8.29元，成交金额7458万元，换手率1.24%，振幅8.36%，量比0.47。复旦张江今日主力资金净流出1185万元，连续3日净流出，上一交易日主力净流出1416万元，今日环比减少16.31%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为45.45%，平均跌幅为2.15%。该股近5个交易日上涨13.87%，主力资金累计净流出4945万元；近20日主力资金累计净流出5333万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410111534069f39bada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410111534069f39bada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2474808180","title":"复旦张江大跌5.08% 净流入减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2474808180","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474808180?lang=zh_cn&edition=full","pubTime":"2024-10-11 10:07","pubTimestamp":1728612429,"startTime":"0","endTime":"0","summary":"10月11日，复旦张江股价大幅下跌，截至10点07分，复旦张江下跌5.08%，报8.40元/股，成交3150万元，换手率0.51%。资金动向截止发稿，复旦张江获得主力净流出932万元，其中超大单流出382万元，大单流出548万元。主营业务及业绩复旦张江公司主营业务为生物医药的创新研究开发、生产制造和市场营销。最新财报显示，今年中报，复旦张江实现营业收入4.08亿元，同比减少21.94%，净利润为7,047.31万元，同比增长2.97%，基本每股收益为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011112251a1dfde28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011112251a1dfde28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-19","address":"上海市浦东新区张江高科技园区蔡伦路308号","stockEarnings":[{"period":"1week","weight":-0.0192},{"period":"1month","weight":0.0545},{"period":"3month","weight":0.3083},{"period":"6month","weight":0.1414},{"period":"1year","weight":-0.115},{"period":"ytd","weight":-0.0441}],"companyName":"上海复旦张江生物医药股份有限公司","boardCode":"AI0027","perCapita":"35761股","boardName":"医药制造业","registeredCapital":"10365万元","compareEarnings":[{"period":"1week","weight":-0.0001},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.1289},{"period":"6month","weight":0.0564},{"period":"1year","weight":0.0849},{"period":"ytd","weight":0.1025}],"survey":"　　上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究开发、生产制造和市场营销。主要产品为盐酸氨酮戊酸外用散、注射用海姆泊芬、抗肿瘤药物长循环盐酸多柔比星脂质体注射液等。其业务主要包括在中国从事研究、开发及销售自行开发的生物医药知识、为客户提供合约制研究、制造及出售医疗产品，以及提供其他医疗服务。公司还通过其子公司从事医疗投资管理、健康产业管理、项目投资、资产管理、投资咨询、商务咨询、医疗咨询及企业战略咨询业务。","serverTime":1730416341871,"listedPrice":8.95,"stockholders":"19870人(较上一季度增加2.03%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,688505,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}